Akero TherapeuticsAKRO
13F holders, Q2 2025 (June 30)257holders +17
55new positions
38sold out
7famous investors
$53.36avg. 13F price*
At the end of Q2 2025, 257 institutions reported holding Akero Therapeutics Inc. (AKRO) in their 13F filings, up 17 from Q1 2025. 55 opened new positions and 38 sold out. The largest holders were Janus Henderson Group PLC ($359.5M), BlackRock, Inc. ($308.4M) and General Atlantic, L.P. ($306.0M). 7 famous investors held it, including Steve Cohen (0.4% of Point72 Asset Management's portfolio), Ken Griffin (0.1% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Akero Therapeutics Inc.
- CUSIP
- 00973Y108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 55 | $345.7M |
| Exits | 38 | $104.0M |
All 13F filers, Q1 2025 → Q2 2025: 18,791,737 shares bought and 13,066,731 shares sold, net +5,725,006 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 257 holders
| Janus Henderson Group PLC | 0.18% | Reduce -4.7% | 6,738,556 | $359.5M |
| BlackRock, Inc. | 0.01% | Reduce -7.6% | 5,779,412 | $308.4M |
| General Atlantic, L.P. | 8.43% | Add +9.6% | 5,733,989 | $306.0M |
| RTW Investments, LP | 4.16% | Reduce -26.2% | 5,477,561 | $292.3M |
| Vanguard Group Inc. | 0.00% | Add +7.1% | 4,529,628 | $241.7M |
| T. Rowe Price Associates Inc. | 0.03% | Reduce -6.4% | 4,509,325 | $240.6M |
| Avoro Capital Advisors LLC | 3.27% | New | 3,500,000 | $186.8M |
| Wellington Management Group LLP | 0.03% | Reduce -42.6% | 3,409,946 | $182.0M |
| Deep Track Capital, LP | 5.22% | Reduce -5.2% | 3,042,598 | $162.4M |
| State Street Corp. | 0.01% | Add +10.1% | 2,745,564 | $146.5M |
| Point72 Asset Management | 0.36% | Add +433.3% | 2,710,929 | $144.7M |
| Woodline Partners LP | 0.70% | Add +413.2% | 2,467,350 | $131.7M |
| UBS Group AG | 0.02% | Reduce -5.9% | 2,028,887 | $108.3M |
| Bellevue Group AG | 2.33% | Add +58.7% | 1,985,272 | $105.9M |
| Alkeon Capital Management LLC | 0.48% | Add +19.3% | 1,850,934 | $98.8M |
| Geode Capital Management, LLC | 0.01% | Reduce -1.5% | 1,722,405 | $91.9M |
| Alliancebernstein L.P. | 0.03% | Add +22.8% | 1,536,200 | $82.0M |
| Marshall Wace, LLP | 0.09% | Reduce -11.8% | 1,418,215 | $75.7M |
| Bank of America Corp. | 0.01% | Add +406.7% | 1,320,461 | $70.5M |
| Logos Global Management LP | 8.55% | No change | 1,200,000 | $64.0M |
| Citadel Advisors | 0.06% | Reduce -38.7% | 1,169,682 | $62.4M |
| Holocene Advisors, LP | 0.14% | New | 1,075,642 | $57.4M |
| Pictet Asset Management Holding SA | 0.05% | Add +213.5% | 986,633 | $52.8M |
| FMR LLC | 0.00% | Reduce -7.7% | 931,926 | $49.7M |
| Perceptive Advisors LLC | 1.83% | Add +15.5% | 915,887 | $48.9M |
| Redmile Group, LLC | 4.40% | Reduce -17.6% | 774,311 | $41.3M |
| Goldman Sachs Group Inc. | 0.01% | Add +56.8% | 765,741 | $40.9M |
| Long Focus Capital Management, LLC | 2.48% | Reduce -1.3% | 720,000 | $38.4M |
| Silverarc Capital Management, LLC | 7.80% | Reduce -0.9% | 713,811 | $38.1M |
| Morgan Stanley | 0.00% | Reduce -13.7% | 693,256 | $37.0M |
| Readystate Asset Management LP | 2.57% | Add +537.7% | 640,923 | $34.2M |
| Rock Springs Capital Management LP | 2.14% | Reduce -4.8% | 640,526 | $34.2M |
| Northern Trust Corp. | 0.00% | Reduce -3.4% | 634,326 | $33.8M |
| Charles Schwab Investment Management Inc. | 0.01% | Add +5.5% | 614,266 | $32.8M |
| Dimensional Fund Advisors LP | 0.01% | Add +8.9% | 573,688 | $30.6M |
| Sofinnova Investments, Inc. | 1.99% | Add +7.6% | 548,788 | $29.3M |
| Loomis Sayles & Co. L P | 0.04% | Add +10.6% | 540,788 | $28.9M |
| Barclays PLC | 0.01% | Add +333.1% | 533,416 | $28.5M |
| EcoR1 Capital, LLC | 1.39% | No change | 440,000 | $23.5M |
| Vivo Capital, LLC | 2.37% | Add +116.1% | 434,689 | $23.2M |
| Voya Investment Management LLC | 0.03% | Add +406.1% | 417,423 | $22.3M |
| Aberdeen Group plc | 0.04% | Reduce -3.7% | 391,600 | $20.9M |
| Principal Financial Group Inc. | 0.01% | Add +51.8% | 390,174 | $20.8M |
| Hudson Bay Capital Management LP | 0.15% | Add +28.0% | 386,523 | $20.6M |
| Summit Partners Public Asset Management, LLC | 0.76% | Reduce -36.7% | 366,997 | $19.6M |
| Frazier Life Sciences Management, L.P. | 0.78% | New | 366,784 | $19.6M |
| Nuveen, LLC | 0.01% | Add +18.9% | 366,769 | $19.6M |
| Jain Global LLC | 0.30% | Add +181.0% | 345,372 | $18.4M |
| Deutsche Bank AG | 0.01% | Add +46.1% | 341,998 | $18.2M |
| University of Wisconsin Foundation | 19.61% | No change | 328,504 | $17.5M |
| Baker Bros. Advisors LP | 0.17% | Reduce -40.8% | 324,630 | $17.3M |
| Siren, L.L.C. | 0.88% | New | 318,647 | $17.0M |
| Millennium Management | 0.02% | Add +36.4% | 314,989 | $16.8M |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.7% | 313,493 | $16.7M |
| Fred Alger Management, LLC | 0.07% | Reduce -39.7% | 310,569 | $16.6M |
| Yiheng Capital Management, L.P. | 5.79% | Reduce -16.7% | 299,791 | $16.0M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Add +51.3% | 295,000 | $15.7M |
| Emerald Advisers, LLC | 0.57% | Reduce -0.9% | 291,692 | $15.6M |
| Ameriprise Financial Inc. | 0.00% | Add +244.1% | 273,445 | $14.6M |
| PFM Health Sciences, LP | 1.26% | New | 266,167 | $14.2M |
| Foresite Capital Management VI LLC | 7.35% | Reduce -32.9% | 244,900 | $13.1M |
| Bank of New York Mellon Corp | 0.00% | Add +11.8% | 237,683 | $12.7M |
| B Group, Inc. | 10.71% | Reduce -4.2% | 232,446 | $12.4M |
| Propel Bio Management, LLC | 14.82% | No change | 228,884 | $12.2M |
| Eagle Health Investments LP | 2.98% | No change | 226,400 | $12.1M |
| Ikarian Capital, LLC | 3.88% | Reduce -10.2% | 220,000 | $11.7M |
| Orbimed Advisors LLC | 0.28% | Add +17.4% | 211,300 | $11.3M |
| Susquehanna International Group, LLP | 0.02% | Add +15.2% | 207,754 | $11.1M |
| Eventide Asset Management, LLC | 0.19% | Reduce -0.3% | 200,000 | $10.7M |
| Rhenman & Partners Asset Management AB | 1.33% | Add +113.6% | 197,600 | $10.5M |
| TD Asset Management Inc | 0.01% | Reduce -8.3% | 191,448 | $10.2M |
| Ensign Peak Advisors, Inc | 0.02% | Add +21.5% | 188,409 | $10.1M |
| Invesco Ltd. | 0.00% | Add +42.9% | 167,305 | $8.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +47.0% | 161,565 | $8.6M |
| Schroder Investment Management Group | 0.01% | Add +28.1% | 149,431 | $8.0M |
| Simplify Asset Management Inc. | 0.47% | No change | 145,609 | $7.8M |
| Schonfeld Strategic Advisors LLC | 0.06% | Reduce -55.0% | 141,306 | $7.5M |
| Manufacturers Life Insurance Company, The | 0.01% | Reduce -8.2% | 138,834 | $7.4M |
| Emerald Mutual Fund Advisers Trust | 0.44% | Reduce -34.2% | 136,297 | $7.3M |
| Russell Investments Group, Ltd. | 0.01% | Reduce -14.7% | 134,939 | $7.2M |
| Avidity Partners Management LP | 1.43% | Add +135.1% | 134,000 | $7.2M |
| Stempoint Capital LP | 2.01% | Reduce -25.2% | 116,779 | $6.2M |
| First Turn Management, LLC | 1.14% | New | 114,554 | $6.1M |
| Nan Fung Trinity (hk) Ltd. | 0.71% | New | 110,650 | $5.9M |
| Rhumbline Advisers | 0.00% | Reduce -2.9% | 107,438 | $5.7M |
| Swiss National Bank | 0.00% | Add +12.3% | 106,400 | $5.7M |
| Great Point Partners LLC | 3.60% | New | 103,848 | $5.5M |
| Balyasny Asset Management L.P. | 0.01% | New | 96,371 | $5.1M |
| Rafferty Asset Management, LLC | 0.02% | Add +25.7% | 93,128 | $5.0M |
| Prudential Financial Inc. | 0.01% | Add +125.0% | 86,490 | $4.6M |
| Jennison Associates LLC | 0.00% | Add +483.3% | 76,863 | $4.1M |
| Corient Private Wealth LP | 0.01% | New | 73,553 | $3.9M |
| Soleus Capital Management, L.P. | 0.27% | Reduce -38.5% | 72,000 | $3.8M |
| AXA S.A. | 0.01% | New | 70,987 | $3.8M |
| J. Goldman & Co LP | 0.11% | Add +123.8% | 65,628 | $3.5M |
| Boothbay Fund Management, LLC | 0.11% | Reduce -12.5% | 63,566 | $3.4M |
| Legal & General Group Plc | 0.00% | Add +20.6% | 60,875 | $3.2M |
| HighVista Strategies LLC | 1.18% | Add +149.3% | 59,993 | $3.2M |
| California State Teachers Retirement System | 0.00% | Add +21.0% | 56,451 | $3.0M |
| Picton Mahoney Asset Management | 0.04% | Add +67.5% | 56,286 | $3.0M |
"% of holder's portfolio" is AKRO's weight in each manager's 13F, not the share of Akero Therapeutics Inc. the manager owns.